Rainbow Children Medicare : Code of conduct under SEBI (PIT) Regulations

I.

June 2, 2022

National Stock Exchange of India Limited

Exchange Plaza,

Plot No. C/1, G Block,

Sandra Kurla Complex

Sandra (E)

Mumbai - 400 051

,r�
Rainbow®	-.BirthRighf
Hospital
Children's	BY RAINBOW HOSPITALS
It takes a lot to treat the little.	Your Right to a Safe Delivery

BSE Limited

Corporate Relationship Department

Phiroze Jeejeebhoy Towers

Dalal Street

Mumbai- 400001

Sub: Intimation of Code of Practices and Procedures for Fair Disclosures of Unpublished Price Sensitive Information ("UPSI")

Dear Sir / Madam,

We wish to inform you that pursuant to Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 ("PIT Regulations") as amended, please find enclosed herewith Code of Practices and Procedures for Fair Disclosures of Unpublished Price Sensitive Information

("UPSI").

We request you to kindly take the same on record.

Thanking You,

Yours faithfully,

For Rainbow Children's Medicare Limited

Ashish Kapil

Company Secretary & Compliance Officer

Rainbow Children's Medicare Limited

Registered Office: 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad, Telangana - 500034

Corporate Office: 8-2-19/1 /a, Daulet Arcade, Karvy lane, Road No.11, Banjara Hills, Hyderabad, Telangana - 500034

Hyderabad:	Banjara Hills - 040 22334455 I Secunderabad - 040 42462200	I	Kondapur IP - 040 42462400 I
	Kondapur OP - 040 42462100 I Hyder Nagar - 040 42462300 I	LB Nagar - 040 71111333
Vijayawada:	Currency Nagar - 0866 6669666 I	Governorpet - 0866 6650250	I	Chennai: Guindy - 044 40122444
Bengaluru:	Marathahalli - 080 71112345 I Bannerghatta Road - 080 25512345	I Hebbal - 080 35061555
Delhi:	Malviya Nagar - 011 66888866	Visakhapatnam: Health City, Chinagadili - 0891 3501601 I Siripuram - 0891 3501555
CIN:U85110TG1998PLC029914	[e-mail]	www.rainbowhospitals.in

RAINBOW CHILDREN'S MEDICARE LIMITED

CODE OF PRACTICES AND PROCEDURES FOR FAIR DISCLOSURES OF UNPUBLISHED PRICE SENSITIVE INFORMATION

CODE OF PRACTICES AND PROCEDURES FOR FAIR DISCLOSURES OF

UNPUBLISHED PRICE SENSITIVE INFORMATION

1. Introduction
   The Securities and Exchange Board of India ("SEBI") notified the SEBI (Prohibition of Insider Trading) Regulations 2015 ("Regulations") on January 15, 2015 and made them effective from May 15, 2015.
   The Regulations envisage every Listed Company to formulate a Code of Practices and Procedures for Fair Disclosures of Unpublished Price Sensitive Information
   ("Code").
   This Code has been framed in accordance with the SEBI (Prohibition of Insider
   Trading) Regulations 2015 as amended from time to time ("Regulations")
2. Objective of the Code
   The Company endeavours to preserve the confidentiality of Unpublished Price Sensitive Information (UPSI) and to prevent its misuse. To achieve this objective and in compliance with the aforesaid regulations, the Board of Directors have adopted this code.
   The Code ensures timely and adequate disclosure of UPSI which could impact the prices of its securities and maintains the uniformity, transparency and fairness in dealing with all its stakeholders.
3. Definitions
4. 1. 'Company' means Rainbow Children's Medicare Limited (hereinafter referred as
      'the Company')
   2. 'Compliance Officer' for the purpose of these regulations means the Company Secretary of the Company.
   3. "Unpublished price sensitive information" ("UPSI") means any information, relating to a company or its securities, directly or indirectly, that is not generally available which upon becoming generally available, is likely to materially affect

Page 2 of 7

CODE OF PRACTICES AND PROCEDURES FOR FAIR DISCLOSURES OF

UNPUBLISHED PRICE SENSITIVE INFORMATION

the price of the securities and shall ordinarily including but not restricted to, information relating to the following:

1. 1. financial results,
   2. dividends,
   3. change in capital structure,
   4. mergers, de-mergers, acquisitions, delisting's, disposals and expansion of business and such other transactions,
   5. changes in Key managerial personnel;
2. "Generally Available Information" means information that is accessible to the public on a non-discriminatory basis.

Words and expressions used in this code and not defined herein but defined in the regulations shall have the meaning respectively assigned to them in the Regulations.

The Company will adhere to the following guidelines so as to ensure fair disclosure of events and occurrence(s) that may impact price of its securities:

4. Norms for disclosure of UPSI

1. Prompt public disclosure of UPSI
   UPSI shall be shared by the Company with stock exchanges promptly and shall also be uploaded on the Company's official website (www.rainbowhospitals.in), in compliance of regulatory requirements and in accordance with Company's Policy on 'Determination of materiality of events / information'.
2. Uniform and Universal dissemination of UPSI
   The disclosure of UPSI shall be on a continuous, immediate, uniform and universal basis and will be universally disseminated except when the same has been disclosed for Legitimate Purposes.
3. Overseeing and coordinating disclosure(s)
   The Compliance Officer shall oversee corporate disclosures and deal with dissemination of information and disclosure of UPSI.

Page 3 of 7

CODE OF PRACTICES AND PROCEDURES FOR FAIR DISCLOSURES OF

UNPUBLISHED PRICE SENSITIVE INFORMATION

The Compliance Officer shall be responsible for ensuring that the Company complies with continuous disclosure requirements and for overseeing and coordinating disclosure of UPSI to stock exchanges, on the website of the Company and to the media.

If any information is accidentally disclosed without prior approval of Compliance Officer the person responsible may inform the Compliance Officer immediately. In such event of inadvertent disclosure of UPSI, the Compliance Officer shall take prompt action to ensure such information is generally available.

In addition to the Compliance Officer, the following persons are also authorized to communicate with the Investors/media:

1. Managing Director
2. Whole-timeDirector
3. Chief Financial Officer

d. Responding to market rumour

The Compliance Officer shall respond to any queries or requests for verification of market rumours by regulatory authorities on behalf of the Company.

The Compliance Officer in consultation with the Managing Director and Chief Financial Officer shall also be responsible for deciding whether a public announcement is necessary for verifying or denying rumours.

The Compliance Officer shall also provide appropriate assistance and fair response to the regulatory authorities including the stock exchanges for verification of news reports and market rumours.

5. Process of disseminating information in order to make the UPSI generally available

1. Disclosure/dissemination of information may be done through various media so as to achieve maximum reach and quick dissemination.

Page 4 of 7